Respiration-related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration

Catheter Cardiovasc Interv. 2022 Feb;99(3):844-852. doi: 10.1002/ccd.30012. Epub 2021 Nov 12.

Abstract

Aims: We evaluated the occurrence and physiology of respiration-related beat-to-beat variations in resting Pd/Pa and FFR during intravenous adenosine administration, and its impact on clinical decision-making.

Methods and results: Coronary pressure tracings in rest and at plateau hyperemia were analyzed in a total of 39 stenosis from 37 patients, and respiratory rate was calculated with ECG-derived respiration (EDR) in 26 stenoses from 26 patients. Beat-to-beat variations in FFR occurred in a cyclical fashion and were strongly correlated with respiratory rate (R2 = 0.757, p < 0.001). There was no correlation between respiratory rate and variations in resting Pd/Pa. When single-beat averages were used to calculate FFR, mean ΔFFR was 0.04 ± 0.02. With averaging of FFR over three or five cardiac cycles, mean ΔFFR decreased to 0.02 ± 0.02, and 0.01 ± 0.01, respectively. Using a FFR ≤ 0.80 threshold, stenosis classification changed in 20.5% (8/39), 12.8% (5/39) and 5.1% (2/39) for single-beat, three-beat and five-beat averaged FFR. The impact of respiration was more pronounced in patients with pulmonary disease (ΔFFR 0.05 ± 0.02 vs 0.03 ± 0.02, p = 0.021).

Conclusion: Beat-to-beat variations in FFR during plateau hyperemia related to respiration are common, of clinically relevant magnitude, and frequently lead FFR to cross treatment thresholds. A five-beat averaged FFR, overcomes clinically relevant impact of FFR variation.

Keywords: clinical research; fractional flow reserve; stable angina.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine
  • Cardiac Catheterization / methods
  • Coronary Angiography
  • Coronary Stenosis* / diagnostic imaging
  • Coronary Stenosis* / therapy
  • Coronary Vessels
  • Fractional Flow Reserve, Myocardial* / physiology
  • Humans
  • Hyperemia*
  • Predictive Value of Tests
  • Respiration
  • Severity of Illness Index
  • Treatment Outcome
  • Vasodilator Agents

Substances

  • Vasodilator Agents
  • Adenosine

Grants and funding